PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 13 |
| 2009 | 9 |
| 2010 | 25 |
| 2011 | 15 |
| 2012 | 14 |
| 2013 | 17 |
| 2014 | 30 |
| 2015 | 18 |
| 2016 | 19 |
| 2017 | 24 |
| 2018 | 18 |
| 2019 | 25 |
| 2020 | 50 |
| 2021 | 44 |
| 2022 | 29 |
| 2023 | 53 |
| 2024 | 46 |
| 2025 | 43 |
| 2026 | 53 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Cancer Metastasis Rev"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Histopathological growth patterns represent a dynamic biological and clinically-relevant terminus of the metastatic cascade.
- Dankner M, Tabariès S, Girondel C, Sillis Y, Vermeulen PB, Siegel PM.
- Cancer Metastasis Rev. 2026 Oct 24;45(4):81. doi: 10.1007/s10555-026-10389-0.
- PMCID: PMC13695687
Dankner M, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13695687 -
Inferring tissue origin from cell-free DNA in metastatic cancer.
- Shu A, Li Y, Sun Q, Yu J, Teng F.
- Cancer Metastasis Rev. 2026 Oct 21;45(4):78. doi: 10.1007/s10555-026-10386-3.
- PMCID: PMC13687128
Shu A, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13687128 -
Histotype and molecular subtype integration in epithelial ovarian cancer: implications for targeted treatment.
- Liu S, Sun C.
- Cancer Metastasis Rev. 2026 Oct 17;45(4):77. doi: 10.1007/s10555-026-10385-4.
- PMCID: PMC13676498
Liu S, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13676498 -
Vascular plasticity in the gastric cancer environment: mechanisms, prognostic significance, and concepts of therapeutic interventions.
- Chmiela M, Jaroniek P, Manzaneque JCR, Balcerczak E, Brzeziński M, Jeleń A, Mani S, Wosiak A, Gonciarz W.
- Cancer Metastasis Rev. 2026 Oct 17;45(4):76. doi: 10.1007/s10555-026-10388-1.
- PMCID: PMC13676513
Chmiela M, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13676513 -
Thymic epithelial tumors: what's next?
- Zhang L, Zhang F, Ismail M, Li G, Rueckert JC.
- Cancer Metastasis Rev. 2026 Oct 14;45(4):75. doi: 10.1007/s10555-026-10384-5.
- PMCID: PMC13669026
Zhang L, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13669026 -
Mechanisms of systemic immune modulation in tumor development: Interactions across lymph nodes, bone marrow, and blood.
- Yu X, Phạm L, de Gruijl TD, Fransen MF, van Maldegem F.
- Cancer Metastasis Rev. 2026 Oct 1;45(4):74. doi: 10.1007/s10555-026-10383-6.
- PMCID: PMC13631006
Yu X, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13631006 -
Homeobox A10 in gastrointestinal malignancies: unraveling metastatic mechanisms and novel therapeutic opportunities.
- Kisling SG, Shah A, Johnson E, Alsafwani ZW, Raman V, Batra SK.
- Cancer Metastasis Rev. Author manuscript. 2026 May 8;45(2):30. doi: 10.1007/s10555-026-10338-x.
- PMCID: PMC13617773
Kisling SG, et al.Cancer Metastasis Rev. Author manuscript. 2026.PMCID: PMC13617773 -
Extracellular vesicles in breast cancer metastasis: functional insights and advances in single-EV analysis.
- Lee Y, Wang Y, Graham P, Beretov J, Ni J.
- Cancer Metastasis Rev. 2026 Sep 24;45(4):73. doi: 10.1007/s10555-026-10382-7.
- PMCID: PMC13612676
Lee Y, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13612676 -
The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications.
- Yang Y, Yin Y, Rong S, Qian Y, Li D, Zhang Y, Wang X.
- Cancer Metastasis Rev. 2026 Sep 23;45(4):72. doi: 10.1007/s10555-026-10380-9.
- PMCID: PMC13601198
Yang Y, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13601198 -
Extracellular vesicles shape tumourigenesis: from signalling networks to systemic progression.
- Telerman SB, Rak J, Telerman A.
- Cancer Metastasis Rev. 2026 Sep 23;45(4):71. doi: 10.1007/s10555-026-10377-4.
- PMCID: PMC13601164
Telerman SB, et al.Cancer Metastasis Rev. 2026.PMCID: PMC13601164